A Study of Single Dose of ABT-333 in Healthy Male Adults

A Double-blind, Randomized, Placebo-controlled Phase 1 Study in Healthy Male Adults to Evaluate the Safety, Tolerability and Pharmacokinetic Profiles of Single Dose of ABT-333

The objectives of this study is to assess the safety, tolerability, and pharmacokinetics of blind, escalating, single, oral doses of ABT-333 under nonfasting conditions in healthy male adult in Japan.

Inclusion Criteria:

• Subject has provided written consent.
• Subject is in general good health.

Exclusion Criteria:

• See above for main selection criteria.